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Abstract
This population-based study compares U.S. effectiveness with 20 Other Western Countries (OWC) in reducing mortality
1989–1991 and 2013–2015 and, responding to criticisms of Britain’s National Health Service, directly compares U.S. with U.
K. child (0–4), adult (55–74), and 24 global mortality categories. World Health Organization Age-Standardized Death Rates
(ASDR) data are used to compare American and OWC mortality over the period, juxtaposed against national average
percentages of Gross Domestic Product (GDP) Expenditure on Health (%GDPEH) drawn from World Bank data. America’s
average %GDPEH was highest at 13.53% and Britain’s the lowest at 7.68%. Every OWC had significantly greater ASDR
reductions than America. Current U.S. child and adult mortality rates are 46% and 19% higher than Britain’s. Of 24 global
diagnostic mortalities, America had 16 higher rates than Britain, notably for Circulatory Disease (24%), Endocrine Disorders
(70%), External Deaths (53%), Genitourinary (44%), Infectious Disease (65%), and Perinatal Deaths (34%). Conversely, U.S.
rates were lower than Britain’s for Neoplasms (11%), Respiratory (12%), and Digestive Disorder Deaths (11%). However, had
America matched the United Kingdom’s ASDR, there would have been 488,453 fewer U.S. deaths. In view of American %
GDPHE and their mortality rates, which were significantly higher than those of the OWC, these results suggests that the U.
S. health care system is the least efficient in the Western world.
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In the recent debate about repealing the Affordable
Health Care Act (“Obamacare”), it was claimed that
Obamacare was more expensive and that state interven-
tion invariably entailed greater inefficiencies than a free
market approach to health care.1 In that debate, the
United Kingdom’s National Health Service (NHS)
system was critically singled out as an exemplar of the
ineffectiveness of what was described as “socialized”
health care, exemplified by the fact that U.K. cancer
survival and cancer mortality rates were higher than
those of the United States.2–4
Trying to compare countries’ health care systems
raises the problem of how to measure the effectiveness
of any nation’s health system. We argue that one key
health-related outcome is reducing amendable mortality
rates. This reflects the UNICEF statement “that in the
last analysis child mortality rates (our emphasis) are an
indicator of how well a nation meets the needs of its
children.”5 We transpose this concept by stating that
amendable mortality rates are indicative of how well a
nation meets the health needs of its population.
Thus does the United States, the richest country in the
world, achieve as good a return for its health investment
by reducing its mortality as well as or better than other
nations?
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From an economic perspective, it might be assumed
there would be a link between a nation’s financial invest-
ment in health and its reduction in mortality rates, the
classic “you get what you pay for.” However, it has long
been known that the United States spends a far higher
percentage of Gross Domestic Product (GDP)
Expenditure on Health (%GDPEH) than any other
country.6–8 Indeed, American researchers Himmelstein
and Woolhandler, long-term critics of the U.S. system,
argue that the U.S. private insurance multi-payer system
is inefficient and over-burdened with administrative
costs and that, despite Obamacare, there continues to
be considerable unmet need.9–13 So, relatively, how
effective is the American health care system?
The answer lies in comparing the United States’ and
the 20 Other Western Countries’ (OWC) World Health
Organization (WHO)-based mortality rates13 and their
%GDPEH, based on World Bank data.6 In addition, in
response to the criticism of “state intervention” as exem-
plified by the United Kingdom’s NHS, we make a direct
comparison of current health outcomes for each of the
24 major global mortality categories between the United
Kingdom and America.
Three specific measures will be used. World Bank
data, extrapolating from 1980 each country’s %
GDPEH to the latest year, including all 27 recorded
years, ending in 2016 from which an average %
GDPEH is calculated.6 To illustrate changes over time,
total %GDPEH levels are given for 2000, 2010, and
2016 and for the percentage of GDPEH that comes
from “private” sources, provided mainly by individuals
or employment-based insurance. This “private” element
is included in the total %GDPEH of each nation, as all
have a proportion of their total %GDPEH that comes
from “private.”6
The “clinical” outcomes are total mortality rates
based on the WHO world population Age-
Standardized Death Rates (ASDR) reported here in
rates per million (pm),13 which are used to compare
the United States with the 20 OWC.
Third, in answer to criticisms of the British NHS, we
undertake a direct comparison between the U.S. and the
U.K. current child mortality rates (CMR 0–4 years) and
adult mortality rates of people aged 55–74 (AMR 55–74
years), which is below the average life expectancy of
Western countries.13 Thus, this age band can be consid-
ered as amendable mortality for all Western nations fol-
lowing health care improvements. In addition are the 24
selected global mortalities categories listed in the U.S.
National Vital Statistics report.14 We use these 24 cate-
gories to undertake a detailed comparison of current
American and British mortality rates.13
It is recognized that there are confounding influences
that affect health outcomes other than a nation’s expen-
diture, such as pre-existing social determinants; a range
of public health and socioeconomic issues, such as access
to health care,15–17 and the continuing problem of a sig-
nificant proportion of U.S. citizens who are not insured
or underinsured.17–19 The strength of this study is that is
brings together issues that are usually examined sepa-
rately and, crucially, this will be the first direct compar-
ative analysis of British and American amendable
mortality outcomes of predominantly “private” vs
“public” health-funded countries.6
The 3 null working hypotheses are that between
1989–1991 and 2013–2015, there will be no significant
differences in reducing amendable mortality:
1. between the United States and the OWC in reducing
Age-Standardized Death Rates (ASDR)
2. between the United States and the United Kingdom
in reducing child (0–4) or adult (55–74) mortality
3. between the U.S. and U.K. death rates of each of the
24 major global mortality categories.14
Methodology
All mortality rates are drawn from WHO annual mor-
tality data, updated December 2018, to compare the
United States and the 20 OWC on the WHO’s world
population Age-Standardized-Death-Rates (ASDR) per
million (pm), which are total death rates controlled for
population and age, using a standardized method adjust-
ing for population demographics.13 The baseline is a 3-
year average of 1989–1991 compared to average index
years for 2013–2015 average, which are the latest avail-
able years. Germany’s baseline years were 1990–1992
and 4 countries (Canada, New Zealand, France, and
Ireland) have earlier index years (2011–2013 or 2012–
2014), are noted in the tables. Each country acts as its
own control by being compared with its own baseline
and index years, from which a ratio of change is
calculated.
Comparing the United Kingdom and United States
Current Mortalities
The direct comparisons between the United States and
the United Kingdom are for current child mortality rates
(CMR 0–4), based on the WHO age bands> 1 year and
1–4 years, from which a mortality rate pm for the CMR
0–4 is calculated. Adult mortality rates (AMR) for
people aged 55–74 years are based on the numbers of
total deaths in the 55- to 74-year-old population to cal-
culate AMR pm.13
The 24 major global mortality categories were exam-
ined where there was a death rate reaching at least 10 pm
in either the United Kingdom or the United States.13
This resolves any issues of differential causes of death,
as the focus is only on global categories, which cover a
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number of separate diagnoses. For example, the global
Circulatory Disease Deaths category includes ischemic
heart disease, cerebrovascular disease, hypertension,
rheumatic hearts disease, and arterial disease-related
deaths. The 10th edition of the International
Classification of Diseases began in 1989 and is used by
the WHO to define global diagnostic categories, hence
our baseline years.13
It should be noted that for the global category
External Deaths, we report on each separate diagnostic
group because of their frequency and because they reflect
psychosocial factors and lifestyles in society. These
include suicide and assault deaths and “Undetermined
deaths.”5,14,15,20–23 The latter group occurs when author-
ities cannot determine whether the death was accidental,
was self-inflicted, or included a third party. But all
involve a degree of lethality similar to suicidal methods
of death;13 accordingly, “undetermined deaths” and
“accidental poisoning” are examined as they are thought
to be a source of likely underreported suicide.23
The economic input into health care is the average
national percentage of %GDPEH drawn from the
World Bank (updated July 2019), based on all years
between 1980 and 2016.6 Thus, %GDPEH can be seen
as a general measure of the financial priority each nation
gives to health and social care, quite irrespective of how
the services are funded or configured.
The World Bank reports on 2 sources of GDP fund-
ing for health. These are “Public,” which come from
federal/national and state sources, and “Private,”
which comes from individual or employment-linked
health insurance plans. The “Public” and combined
“Private” percentages are the total %GDPEH of each
nation.6 Total %GDP is given for the years 1980, 2000,
2010, and 2016 to illustrate the changes over the period.
For reasons of space, only the %GDP coming from
“Private” sources is shown for the latest year available
(2016). It should be noted that every country has made
substantial increases in %GDPEH since 1980. However,
it is known that the United Kingdom has long had one
of the lowest %GDP devoted to health and the United
States one of the highest.4,6–9,13 A ratio of change is cal-
culated for each OWC average %GDPEH and com-
pared to the U.S. average, from which an odds ratio is
calculated. Finally, the percentage of GDPEH that
comes from “Private” sources is shown to give an indi-
cation of the “Public/Private” funding configuration of
each country.6
The data commenced in 1980 and continued to 2016,
but no data was reported for the years 1982, 1983, 1985,
1992, 1996, 2002, 2003, 2006, 2007, and 2009. In addi-
tion, there was no %GDPEH-reported data for
Australia in 2004 and 2008, for Belgium in 2004, for
Denmark in 2008, for Germany in 2004, for Greece in
1994, 2004, and 2008, and for Japan in 2004 and 2008.6
The numbers of missing years for each country are indi-
cated in Table 1.
An inherent problem of international comparisons is
how different health and social policies and configura-
tions of health services might influence health outcomes.
This would require country-specific research to resolve
this problem and is outside the scope of this study.
Nevertheless, the %GDPEH is a reasonable measure
of the fiscal priority each country gives to its health
and social care services.
Statistics
We used the SPSS statistical package from which
Confidence Intervals (to 95% significance) are calcu-
lated to compare changes in ASDR over the period
between the United States and the OWC, all controlled
for total population.13 The comparison between U.S.
and U.K. current child (0–4) and adult (55–74) mortal-
ities and the 24 global mortality categories are based on
the average of years 2013–2015 in rates pm. A series of
U.K. to U.S. odds ratios are calculated for each of the
current rates of the global diagnostic mortality
categories.
Results
%GDP Expenditure on Health
Table 1 presents changes in %GDPEH between 1980
and 2016. Over the period, the United States always
had the highest current and average %GDPEH
(17.07% and 13.53%, respectively). Apart from
America, only France, Germany, and Switzerland aver-
aged above 10% of GDP being devoted to health care
over the period. The lowest average %GDPEH was the
United Kingdom at 7.68%, followed by Greece at 7.71%
and Spain at 7.77%, with the overall OWC average
being 8.79%.
The fifth column of Table 1 lists the percentage of
GDP on health coming from “Private” sources.
Unsurprisingly, the United States has the highest
“Private” input at 9.15%, followed by Switzerland at
4.8% and the Netherlands at 4.02%. The lowest propor-
tion of %GDP coming from “Private” sources was
Denmark at 1.33%, Norway at 1.53%, and the United
Kingdom at 1.58%, with an OWC average of 2.09% and
the remaining 6.7% of national GDP coming from
“Public” sources.
The proportion of total health expenditure coming
from “Private” sources was more varied than expected,
as only 54% of total American %GDPEH came from
“Private” sources, meaning there were considerable
funds via federal and state funding. There were highs
of 40% from “Private” sources in Australia and
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Netherlands and in Switzerland 39% contributing to
total %GDPEH. The “lowest” proportions of
“Private” contributions to total %GDPEH were found
in Denmark at 13%, Norway at 15%, and the United
Kingdom at 16%. The OWC average “Private” source
was 24%.
The odds ratio of OWC and United States of average
%GDPEH was 1:1.54 over the whole period, with 12
countries having ratios of wider ratios than> 1:1.50.
As the United Kingdom had the lowest average %
GDPEH of all countries reviewed, the widest odds
ratio was between Britain and America at 1:1.76.
It is noteworthy that in the specific years shown
(1980, 2000, 2010, and 2016), U.S. spending on health
rose in proportion to what the OWC were spending, as
the ratio in 1980 was 1:1.32 but by 2016 had risen to
1:1.71, indicating that over the period, the United
States was relatively increasing its %GDPEH compared
to the OWC.
Comparing Other Western Countries to U.S.
Age-Standardized Death Rates
Table 2 presents the changes in total mortality rates pm
between 1989–1991 and 2013–2015. The United States
had the highest current ASDR at 4,772 pm, followed by
Germany at 4,173 pm and Portugal at 4,136 pm. The
lowest ASDR were in Japan at 3,084 pm, Switzerland at
3,326 pm, and Australia at 3,420 pm.
The United States had the smallest reduction in
ASDR at just 23% over the period, compared to an
average 34% decline in the OWC. The United
Kingdom was seventh highest at 4,044 pm, which repre-
sented a drop of 36%, meaning that American ASDR
were 18% higher than the United Kingdom.
Confidence Interval analysis showed that every
Western country had a statistically significant larger
reduction in total mortality than the United States
over the period.
Comparing United Kingdom to United States on
24 Mortality Categories
Table 3 presents the differences between current U.K.
and U.S. mortality for children (0–4) and adults (55–
74) and for the 24 global mortality categories.
America’s child mortality was 1,249 pm compared to
the United Kingdom’s 885pm, which means that U.S.
rates were 46% higher than Britain’s.
Table 1. Total % GDP Expenditure on Health 1980–2016. OWC vs U.S. Current Government % Health Expenditure and U.S. average %















1. U.S. 9.0 13.4 17.1 17.07 13.53 1:1.00
2. Switzerland 7.3 10.2 10.9 12.25 10.17 1:1.34
3. Germany [1] 8.4 10.1 11.6 11.14 10.16 1:1.33
4. France 7.0 10.3 11.6 11.54 10.13 1:1.34
5. Canada 7.0 8.8 11.1 10.53 9.82 1:1.38
6. Austria [2] 7.4 9.0 11.1 10.44 9.64 1:1.40
7. Belgium [1] 6.3 9.0 10.6 10.04 9.32 1:1.45
8. Denmark [1] 8.9 8.3 11.1 10.3 9.10 1:1.49
9. Netherlands 7.4 8.0 12.1 10.36 9.08 1:1.49
10. Sweden 8.9 8.2 9.5 10.93 8.85 1:1.53
11. Norway 7.0 8.4 9.4 10.0 8.55 1:1.58
12. Australia [2] 6.1 8.0 8.9 9.25 8.46 1:1.60
13. New Zealand 5.9 7.7 10.0 9.22 8.37 1:1.62
14. Japan [2] 6.5 7.7 9.6 10.93 8.34 1:1.62
15. Finland 6.3 7.2 9.0 9.49 8.32 1:1.63
16. Italy 7.0 8.1 9.4 8.94 8.15 1:1.66
17. Portugal [1] 5.3 8.8 10.9 9.08 8.13 1:1.66
18. Ireland 8.2 6.1 9.2 7.38 8.03 1:1.68
19. Spain 5.3 7.2 9.6 9.2 7.77 1:1.74
20. Greece [3] 5.9 7.9 9.5 8.4 7.71 1:1.75
21. U.K 5.6 7.0 9.4 9.9 7.68 1:1.76
OWC (-U.S.) average 6.8 8.3 10.2 9.97 8.79 8.81
OWC: U.S. ratios 1:1.32 1:1.61 1:1.68 1:1.71 1.54 1:1.54
Abbreviations: GDP, gross domestic product; GDPEH, GDP expenditure on health (%); OWC, other Western countries.
Missing years in brackets. Bold values highlight US and UK expenditures.
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U.K. adult (55–74) rates were 10,568 pm to the U.S.
12,544 pm, which were 19% higher than the United
Kingdom’s adult rate.
In 2015, the latest year for which we have WHO mor-
tality data, total numbers of U.S. deaths were 2,713,630.
Thus, if America had matched Britain’s ASDR in 2015,
there would have been 488,453 fewer U.S. deaths,
including 10,789 fewer child deaths (0–4).
America had substantially higher rates than Britain
for 16 categories of the 24 mortality categories.
These were as follows: U.K. to U.S. Perinatal Deaths
(2,066 pm to 3,113 pm), Circulatory Disease Deaths
(1,010 pm to 1,326 pm), Total Neurological (497pm to
564pm), Total External Deaths (257pm to 548pm),
Endocrine Disorders (63pm to 213pm), Infectious
Diseases (47pm to 136pm), Genitourinary Disorders
(61pm to 108pm), Congenital Conditions (33pm to
37pm), Blood and Immune Disorders (10pm to 20pm),
and deaths surrounding childbirth (4pm to 14pm).
Substantial U.K. to U.S. odds ratios (> 1:1.20) for
mortalities reaching at least 100pm were Endocrine
Disorder Deaths (1:3.41), Infectious Disease (1:2.93),
Genitourinary (1:1.79), Perinatal (1:1.51), Circulatory
Disease (1:1.31), and Neurological Disease Deaths
(1:1.13), which include such conditions as motor neu-
rone disease, Parkinson’s disease, and multiple system
atrophy, but not Alzheimer’s and other dementias,
which were virtually identical in the 2 countries.
Notable total external deaths included suicide, yielding
U.K. to U.S. ratios of (1:1.79), transports deaths
(1:4.23), assaults (1:27.5), and accidental poisoning
(1:2.51), which is associated with underreported suicides.
Conversely, there were 5 substantial mortality catego-
ry death rates (> 100pm) in which Britain had higher
rates than America: Neoplasms (1,273 pm to 1,138 pm,
yielding a U.K. to U.S. odds ratios of 1:0.89),
Respiratory Diseases (496pm to 438pm, a 1:0.88 ratio),
Mental and Behavioral Disorders (242pm to 203pm, a
1:0.83 ratio), Digestive Disorder Deaths (221pm
to197pm, a1:0.89 ratio), and Undetermined Deaths
(102pm to 87pm, a 1:0.85 ratio).
In addition, the United Kingdom had slightly higher
rates than America for Problematic Signs and Symptoms
(68pm to 67pm), Skeletal and Connective (29pm to
25pm), and Skin-Related Deaths (13pm to 8pm).
Discussion
It is readily acknowledged that a complex range of inter-
active, multiple causes influence national mortality
rates,15–17 but relative poverty is especially linked to
child mortality, although the underlying mechanism is
not fully understood.15–17,24–27 Lifestyles and what
might be described as the local “geography” of
Table 2. Age-Standardized Deaths All Cause Deaths per Million 1989–1991 vs 2013–2015: CIs Used to Compare OWC With U.S.












1-9. U.S. 6,203 4,772 223% 1:1.00 1:1.00 1:1.00
2-5. Germany 6,456 4,173 35% 1:1.19 1:1.13 1:1.26
3-2. Portugal 2012–2014 7,086 4,136 42% 1:1.32 1:1.25 1:1.39
4-4. Denmark 6,512 4,124 37% 1:1.21 1:1.15 1:1.28
5-10. Belgium 6,151 4,081 34% 1:1.16 1:1.10 1:1.22
6-1. Ireland 2012–2014 7,127 4,065 43% 1:1.35 1:1.28 1:1.42
7-6. U.K. 6,340 4,044 236% 1:1.21 1:1.14 1:1.27
8-13. Greece 5,694 3,995 30% 1:1.10 1:1.04 1:1.16
9-3. Finland 6,613 3,985 40% 1:1.28 1:1.21 1:1.35
10-7. Austria 6,334 3,945 38% 1:1.24 1:1.17 1:1.3
11-12. Netherlands 5,739 3,898 32% 1:1.13 1:1.07 1:1.2
12-8. New Zealand 2011–2013 6,278 3,879 38% 1:1.25 1:1.18 1:1.32
13-11. Norway 5,862 3,697 37% 1:1.22 1:1.15 1:1.29
14-18. Sweden 5,420 3,688 32% 1:1.13 1:1.07 1:1.2
15-17. Canada 2011–2013 5,504 3,663 33% 1:1.16 1:1.09 1:1.22
16-19. France 2012–2014 5,377 3,604 33% 1:1.15 1:1.08 1:1.21
17-14. Italy 5,675 3,455 39% 1:1.26 1:1.19 1:1.34
18-15. Spain 5,670 3,422 40% 1:1.27 1:1.20 1:1.35
19-16. Australia 5,641 3,420 39% 1:1.27 1:1.20 1:1.34
20-20. Switzerland 4,930 3,326 33% 1:1.14 1:1.08 1:1.21
21-21. Japan 4,675 3,084 34% 1:1.17 1:1.10 1:1.24
Average (-U.S.) 5,735 3,784 34%
Abbreviations: ASDR, age-standardized death rate; CI, confidence interval; OWC, other Western countries.
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American states are other factors.27–29 However, placing
these results within the context of each nation’s fiscal
investment to health poses the question of comparative
effectiveness of the different countries. Although %
GDPEH is but one aspect of health care delivery, it is
the major economic indicator of a nation’s fiscal com-
mitment to the health needs of its population.
One surprising finding was that only 54% of total
U.S. health expenditure came from “Private” sources,
which highlights the considerable funds coming from
federal and state provision, yet as the U.S. system is
still based on an insurance model, there remains the
problem of limited or underinsured people not having
their health needs met.1,6,11,16–18,24,25 Indeed, it has long
been known that American health is more expensive in
part because of over-prescription, overuse of high-tech
measures, and higher administrative costs—in effect,
“spending more and getting less.”6,9–11,30–34 Although
it has been recognized that the not-for-profit systems
are less costly,33 it is still being argued that the Obama
Reform was “no cure for what ails us”;35 although this is
possibly complicated by interactive socioeconomic fac-
tors,14–18,24–27 it is predominately because health care is
delivered via an insurance system that needs to make a
profit.7,32,33
The 3 null hypotheses are rejected as the United
States had significantly higher mortality rates than the
20 OWC and, compared to the United Kingdom, had
significantly higher rates for child and adult mortality
and for most of the global diagnostic categories.
Indeed, as all the other countries had significantly
lower ASDR than America, this suggests that the U.S.
health care system is the least efficient of the 20 Western
nations in reducing amendable mortality. This study also
shows that of the specific mortality categories, the
United Kingdom had lower rates in 16 of the 24 catego-
ries, and had American matched the United Kingdom’s
overall mortality rates, there would have been 488,433
fewer American deaths. This raises questions as to
whether the money spent on health reaches the patient,
Table 3. U.K. Compared to U.S., Child and Adult Mortality and Current Global Diagnostic Death Rates per Million (pm)> 10 pm. 2013–
2015.
Category-U.K. lower than U.S. U.K. U.S. U.K.: U.S. Ratio
Child mortality (0–4 years) 855pm 1,249 pm 1:1.46
Adult mortality (55–74 years) 10,568 pm 12,544 pm 1:1.19
1. Perinatal deaths (< 1year) 2,066pm 3,113pm 1:1.51
2. Circulatory disease deaths 1,010 pm 1,326 pm 1:1.31
3. Nervous disease 188pm 256pm 1:1.36
4. Alzheimer 309pm 308pm 1:1.00
Total neurological deaths 497pm 564pm 1:1.13
5. Accidental poisoning 59pm 148pm 1:2.51
6. Suicide 67pm 120pm 1:1.79
7. Transport 26pm 110pm 1:4.23
8. Falls 98pm 104pm 1:1.06
9. Assault 2pm 55pm 1: 27.5
10. Drowning 5pm 11pm 1:2.13
Total external deaths 257pm 548pm 1:2.13
11. Endocrine disorders 63pm 213pm 1:3.38
12. Infectious diseases 47pm 136pm 1:2.89
[includes HIV] 2pm 18pm 1:9.00
13. Genitourinary disorders 61pm 108pm 1:1.79
14. Congenital conditions 33pm 37pm 1:1.12
15. Blood and immune disorders 10pm 20pm 1:2.00
16. Pregnancy and childbirth-female 4pm 14pm 1:3.50
Category U.K. higher than U.S.
17. Neoplasms 1,273 pm 1,138 pm 1:0.89
18. Respiratory 496pm 438pm 1:0.88
19. Mental and behavioral 242pm 202pm 1:0.83
20. Digestive disorders 221pm 197pm 1:0.89
21. Undetermined deaths [external] 102pm 87pm 1:0.85
22. Problem signs and symptoms (< 1) 68pm 67pm 1:0.99
23. Skeletal and connective 29pm 25pm 1:0.86
24. Skin 13pm 8pm 1:0.62
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as America’s failure to match Britain’s total mortality
suggests that the United States does not get a good
“lifesaving” return on its health care investment.
We can only briefly speculate on possible factors that
might have contributed to the key differences between
the U.K. and U.S. results.
The 6 biggest global mortality rates for which
America exceeds Britain possibly reflect something of
the lifestyle and culture of the United States. The prob-
lems of obesity appear to be reflected in the very high U.
S. circulatory and endocrine disorder deaths, which
include diabetes.36 Then there is the issue of relative pov-
erty, as the United States has long had the widest income
inequality of all 21 Western countries, which might be
reflected in the high infectious disease and perinatal
deaths, as again the United States has long had the high-
est rates of child mortality (0–4) in the OWC, which is
related to relative poverty.15–17,25–27,37 The differential
results in HIV and external deaths—especially the
higher suicide, transport, and assault deaths—appear
to mirror differing societal lifestyles. One notable
difference between the other nations is the extent of
gun-related deaths in America linked to suicide and
homicide,38,39 conservatively estimated at more than
30,000 p.a., which far exceeds any other Western
country.40
Finally, based on the most authoritative data sources
(namely the WHO and World Bank), this study shows
that the predominantly universal British NHS compares
very favorably to the United States, as America achieved
proportionately less with relatively more, whereas the
United Kingdom achieved proportionally more with rel-
atively less. This gives support to the American policy
analysts who asked, “Is American health care uniquely
inefficient?”34
Whatever the answer to this question, attempts by
opponents of the Affordable Health Care Act to portray
the U.K. health care system as an exemplar of the inef-
fectiveness of “socialized health” is without empirical
merit, and Britain’s substantially lower death rate com-
pared to that of the United States should be a boost for
frontline NHS staff, patients, and families.
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